Baron, Alain D.

Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans

Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 3,931

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,687

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

DeFronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 1,559

Effects of exenatide (Exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes

Buse, J. B., Henry, R. R., Han, J., Kim, D. D., Fineman, M. S., Baron, A. D., & for the Exenatide-113 Clinical Study Group (2004) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 1,346

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

Kendall, D. M., Riddle, M. C., Rosenstock, J., Zhuang, D., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 1,177

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.

Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular and exercise physiology

Cited by 930

Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation

Steinberg, H. O., Tarshoby, M., Monestel, R., Hook, G., Cronin, J., Johnson, A., Bayazeed, B., & Baron, A. D. (1997) · Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 761

Impaired Insulin-Mediated Skeletal Muscle Blood Flow in Patients With NIDDM

Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1992) · Diabetes

Diabetes, Cardiovascular Risks, and LipoproteinsMetabolism, Diabetes, and Cancer

Cited by 470

Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance

Garvey, W. T., Maianu, L., Zhu, J. H., Brechtel-Hook, G., Wallace, P., & Baron, A. D. (1998) · Journal of Clinical Investigation

Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 459

Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies

Roth, J. D., Roland, B. L., Cole, R. L., Trevaskis, J. L., Weyer, C., Koda, J. E., Anderson, C. M., Parkes, D. G., & Baron, A. D. (2008) · Proceedings of the National Academy of Sciences

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 436

Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications

Mather, K. J., Hunt, A. E., Steinberg, H. O., Paradisi, G., Hook, G., Katz, A., Quon, M. J., & Baron, A. D. (2001) · The Journal of Clinical Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 363

The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-Term Pharmacokinetic and 12-Week Dose-Ranging Studies

Buse, J. B., DeFronzo, R. A., Rosenstock, J., Kim, T., Burns, C., Skare, S., Baron, A., & Fineman, M. (2016) · Diabetes Care

Diabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

Cited by 325

Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics

Baron, A. D., Schaeffer, L., Shragg, P., & Kolterman, O. G. (1987) · Diabetes

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 308

HbA1c Measurement Improves the Detection of Type 2 Diabetes in High-Risk Individuals With Nondiagnostic Levels of Fasting Plasma Glucose

Perry, R. C., Shankar, R. R., Fineberg, N., McGill, J., & Baron, A. D. (2001) · Diabetes Care

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 150

Effects of exenatide alone and in combination with daclizumab on β-cell function in long-standing type 1 diabetes

Rother, K. I., Spain, L. M., Wesley, R. A., Digon, B. J., Baron, A., Chen, K., Nelson, P., Dosch, H.-M., Palmer, J. P., Brooks-Worrell, B., et al. (2009) · Diabetes Care

Diabetes Treatment and ManagementDiabetes and associated disorders

Cited by 133

Insulin resistance in the vasculature

Mather, K. J., Steinberg, H. O., & Baron, A. D. (2013) · Journal of Clinical Investigation

Diabetes, Cardiovascular Risks, and LipoproteinsNitric Oxide and Endothelin Effects

Cited by 120

Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action

Shankar, R., Zhu, J. S., Ladd, B., Henry, D., Shen, H. Q., & Baron, A. D. (1998) · Journal of Clinical Investigation

Pancreatic function and diabetesNitric Oxide and Endothelin Effects

Cited by 79

In Vivo Regulation of Non-Insulin-Mediated and Insulin-Mediated Glucose Uptake by Cortisol

Baron, A. D., Wallace, P., & Brechtel, G. (1987) · Diabetes

Pancreatic function and diabetesAdrenal Hormones and Disorders

Cited by 56